Obstructive Lung Disease

Cystic Fibrosis Updates in Care: Part II — The “Sweat Sticker” and Clinician Q&A

By

Tori Rodriguez, MA, LPC, AHC

Publish Date May 21, 2021

In honor of Cystic Fibrosis Awareness Month, we present a 2-part series on treatment updates in the field, including the “sweat sticker.”

Primary Ciliary Dyskinesia: Practical Pearls for Diagnosis

By

Suzanne Bujara

Publish Date January 28, 2019

Recent guidelines set forth by an interdisciplinary panel assembled by the American Thoracic Society sought to demystify primary ciliary dyskinesia and address 4 main diagnostic questions.

Is There an “Ideal” Cystic Fibrosis Candidate for Lung Transplantation?

By

Suzanne Bujara

Publish Date August 23, 2018

Lung transplantation can extend survival in patients with cystic fibrosis who have compromised lung function and increasing exacerbations.

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

Publish Date May 9, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

Azithromycin in Pediatric Bronchiectasis: What Factors Influence Efficacy? 

By

Sheila Jacobs

Publish Date September 26, 2022

How long after initiating azithromycin is the treatment effective in children with bronchiectasis unrelated to cystic fibrosis, and what factors may modify azithromycin’s effects?

Antibiotic Eradication of P. Aeruginosa Improves Long Term Lung Function in CF

By

Ron Goldberg

Publish Date September 23, 2022

Less long-term deterioration in FEV1 occurred in patients with cystic fibrosis whose P. aeruginosa infection during childhood had been successfully eradicated by AET.

Pulmonary Fibrosis Patient Registry Data Reveal PF, ILD Outcome Variations

By

Tori Rodriguez, MA, LPC, AHC

Publish Date August 5, 2022

Research based on Pulmonary Fibrosis Foundation Patient Registry data highlight potential disparities in the diagnosis, prognosis, and management of PF and ILD.

Symptomatic Undiagnosed COPD and Asthma: Disease Burden and Quality of Life

By

Ron Goldberg

Publish Date August 2, 2022

How do individuals with undiagnosed asthma and COPD manifest these conditions over time, and how do these undiagnosed conditions affect quality of life?

Idiopathic Pulmonary Fibrosis: Effect of Diagnostic Delay on Outcomes, QOL

By

Colby Stong

Publish Date August 1, 2022

For patients with IPF, how does diagnostic delay affect quality of life as well as hospitalization and progression-free survival rates?

Dyspnea in Obesity Linked to Reduction in Lung Volumes, Higher BMIs

By

Sheila Jacobs

Publish Date April 29, 2022

In patients with obesity, what relationships exist between dyspnea in daily living, lung function, and body composition?

Modified Lung Ultrasound for Evaluating Bronchopulmonary Dysplasia Severity

By

Virginia A. Schad, PharmD, RPh

Publish Date April 18, 2022

Researchers adapted the lung ultrasound score to evaluate bronchopulmonary dysplasia severity and short-term clinical outcomes in preterm infants.